Cargando…

MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7

Malignant gliomas are the most common tumor in central nervous system with poor prognosis. Due to the limitation of histological classification in earlier diagnosis and individualized medicine, it is necessary to combine the molecular signatures and the pathological characteristics of gliomas. Lots...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhi-Qin, Ren, Jing-Jing, Zhao, Jun-Long, Zang, Jian, Long, Qian-Fa, Du, Jing-Jing, Jia, Xiao-Tao, Gu, Nai-Bing, Di, Zheng-Li, Qian, Yi-Hua, Li, San-Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058039/ https://www.ncbi.nlm.nih.gov/pubmed/32139705 http://dx.doi.org/10.1038/s41598-020-60218-9

Ejemplares similares

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide
por: Wang, Xu, et al.
Publicado: (2022)

miR-139/PDE2A-Notch1 feedback circuit represses stemness of gliomas by inhibiting Wnt/β-catenin signaling
por: Li, San-Zhong, et al.
Publicado: (2021)

MicroRNA-144 regulates angiotensin II-induced cardiac fibroblast activation by targeting CREB
por: Liu, Zhi-Yong, et al.
Publicado: (2020)

CUL4B Promotes Temozolomide Resistance in Gliomas by Epigenetically Repressing CDNK1A Transcription
por: Ye, Xiang, et al.
Publicado: (2021)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

AEG-1 silencing attenuates M2-polarization of glioma-associated microglia/macrophages and sensitizes glioma cells to temozolomide
por: Li, Jing, et al.
Publicado: (2021)

A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
por: Hu, Zhifang, et al.
Publicado: (2020)

Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide
por: Gerstmeier, Julia, et al.
Publicado: (2021)

LncRNA RP1-86C11.7 exacerbates the glioma progression and oncogenicity by hsa-miR-144-3p/TFRC signaling.
por: Ma, Qiong, et al.
Publicado: (2021)

Interactions of Rabconnectin-3 with Cav2 calcium channels
por: Gandini, Maria A., et al.
Publicado: (2019)

Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
por: Lv, Qiao-Li, et al.
Publicado: (2020)

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
por: Gu, Qiang, et al.
Publicado: (2023)

Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux
por: Wen, Zhi-peng, et al.
Publicado: (2019)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022)

MiR‐646 suppresses proliferation and metastasis of non‐small cell lung cancer by repressing FGF2 and CCND2
por: Wang, Jing, et al.
Publicado: (2020)

SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
por: Dai, Shuang, et al.
Publicado: (2018)

Nerve injury elevates functional Cav3.2 channels in superficial spinal dorsal horn
por: Feng, Xiao-Jin, et al.
Publicado: (2019)

The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects
por: Shen, Hong-Yuan, et al.
Publicado: (2022)

Repression of myogenic differentiation by aFGF, bFGF, and K-FGF is dependent on cellular heparan sulfate
Publicado: (1992)

Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
por: Dai, Shuang, et al.
Publicado: (2019)

Altered FGF Signaling Pathways Impair Cell Proliferation and Elevation of Palate Shelves
por: Wu, Weijie, et al.
Publicado: (2015)

microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma
por: Zheng, Qian, et al.
Publicado: (2020)

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
por: Tu, Zewei, et al.
Publicado: (2022)

Genetic variation at the microRNA binding site of CAV1 gene is associated with lung cancer susceptibility
por: Fang, Xue, et al.
Publicado: (2017)

Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity
por: Tu, Zewei, et al.
Publicado: (2022)

MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1
por: Wu, Hao, et al.
Publicado: (2014)

miR-9-5p Mediates ABCC1 to Elevate the Sensitivity of Glioma Cells to Temozolomide
por: Chen, Xiang-Rui, et al.
Publicado: (2021)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma
por: Chen, Wei-Lin, et al.
Publicado: (2019)

MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta‐analysis
por: Zhou, Qian, et al.
Publicado: (2018)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

Glioma and temozolomide induced alterations in gut microbiome
por: Patrizz, Anthony, et al.
Publicado: (2020)

Temozolomide Chronotherapy in Glioma: A Systematic Review
por: Jia, Jason L., et al.
Publicado: (2023)

CTRP13 attenuates the expression of LN and CAV-1 Induced by high glucose via CaMKKβ/AMPK pathway in rLSECs
por: Zhang, Qi, et al.
Publicado: (2020)

Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Wei, Shoufeng, et al.
Publicado: (2022)

Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide
por: Yang, Zhang-Jian, et al.
Publicado: (2021)

Low magnitude of tensile stress represses the inflammatory response at intervertebral disc in rats
por: Han, Chao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tjepnjfs4oc6uqa2fi9em5m5ui